Cardiovascular Risk, Label Reading Not Mentioned In Aleve Ad
This article was originally published in The Tan Sheet
Executive Summary
A new Aleve television ad makes no mention of cardiovascular risk and describes the OTC pain reliever as "safe and strong.
You may also be interested in...
FDA’s Ganley “Disappointed” By Competitive Pain Reliever Marketing
FDA OTC head Charles Ganley, MD, chastised OTC pain reliever marketers for airing comparative DTC ads in the wake of COX-2 safety concerns during a speech May 6 at the Consumer Healthcare Products Association Regulatory & Scientific Conference in Washington, D.C
FDA’s Ganley “Disappointed” By Competitive Pain Reliever Marketing
FDA OTC head Charles Ganley, MD, chastised OTC pain reliever marketers for airing comparative DTC ads in the wake of COX-2 safety concerns during a speech May 6 at the Consumer Healthcare Products Association Regulatory & Scientific Conference in Washington, D.C
FDA’s Ganley “Disappointed” By Competitive Pain Reliever Marketing
FDA OTC head Charles Ganley, MD, chastised OTC pain reliever marketers for airing comparative DTC ads in the wake of COX-2 safety concerns during a speech May 6 at the Consumer Healthcare Products Association Regulatory & Scientific Conference in Washington, D.C